Sato pharma was established in 2014, it was the idea of the owner and CEO Dr.Anwar Gaweesh to start a national pure Egyptian pharmaceutical business that handle products in specialized areas. The name SATO was derived from our basic believe that Success is Acquired by Talented Operators. In addition to the current CNS portfolio, SATOPHARMA is launching a group of new products in 2020 and 2021 to cover different therapeutic areas like antibiotics , anti-inflammatories , disinfectants , cold therapies , multivitamins , respiratory system diseases , skin and soft tissue and skeleto- muscular area . Now Sato pharma has different departments including Sales ,Marketing ,SFE ,Legal Affairs ,HR, Pharmacovigilance, R&D ,Registeration, Finanace. The Sales department cover all regions of Egypt.
| Website | https://satopharma.com/ |
| Revenue | $3 million |
| Employees | 81 (53 on RocketReach) |
| Founded | 2014 |
| Address | 9 Ismael El-Mazni St, From Ammar Ibn Yasser, Nozha, Cairo, Cairo, EG |
| Phone | +20 11 00993636 |
| Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
| Competitors | Johnson & Johnson, Roche, Novartis, Merck & Co., Inc., Pfizer, Bristol Myers Squibb, Amgen, Takeda, Gilead Sciences, アステラス製薬(株) +46 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Sato Pharma employee's phone or email?
The Sato Pharma annual revenue was $3 million in 2026.
Anwar Gaweesh is the CEO of Sato Pharma.
53 people are employed at Sato Pharma.
Sato Pharma is based in Cairo, Cairo.
The NAICS codes for Sato Pharma are [32, 32541, 3254, 325].
The SIC codes for Sato Pharma are [283, 28].